34.28
1.15%
0.39
Finanzdaten der Harmony Biosciences Holdings Inc-Aktie (HRMY)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
8.19%
154.62
|
168.41 | 160.27 | 134.22 | 119.13 |
Cost Of Revenue |
36.31%
27.48
|
43.15 | 32.30 | 25.01 | 20.78 |
Gross Profit |
1.49%
127.13
|
125.26 | 127.97 | 109.21 | 98.35 |
Operating Expenses
|
11.72%
75.10
|
85.06 | 63.46 | 62.31 | 57.92 |
Interest Income/Expense |
4.535
|
- | - | - | - |
Benefits Costs and Expenses |
20.12%
102.83
|
128.72 | 108.44 | 90.12 | 81.35 |
Costs And Expenses |
20.12%
102.83
|
128.72 | 108.44 | 90.12 | 81.35 |
Operating Income/Loss |
29.45%
52.03
|
40.20 | 64.51 | 46.90 | 40.42 |
Income/Loss From Continuing Operations Before Tax |
30.48%
51.78
|
39.69 | 51.83 | 44.09 | 37.78 |
Income Tax Expense/Benefit |
2.82%
13.45
|
13.08 | 13.37 | 9.795 | 8.295 |
Income/Loss From Continuing Operations After Tax |
44.07%
38.33
|
26.61 | 38.46 | 34.30 | 29.48 |
Net Income/Loss
|
44.07%
38.33
|
26.61 | 38.46 | 34.30 | 29.48 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
14,758%
56.77
|
-0.3873 | 59.86 | 59.97 | 59.73 |
Diluted Average Shares |
11,164%
57.60
|
-0.5206 | 60.68 | 60.74 | 61.22 |
Basic Earnings Per Share |
47.83%
0.68
|
0.46 | 0.64 | 0.57 | 0.49 |
Diluted Earnings Per Share |
48.89%
0.67
|
0.45 | 0.63 | 0.56 | 0.48 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):